Switch to: Citations

Add references

You must login to add references.
  1. Does Controlled Donation after Circulatory Death Violate the Dead Donor Rule?Emil J. Nielsen Busch & Marius T. Mjaaland - 2022 - American Journal of Bioethics 23 (2):4-11.
    The vital status of patients who are a part of controlled donation after circulatory death (cDCD) is widely debated in bioethical literature. Opponents to currently applied cDCD protocols argue that they violate the dead donor rule, while proponents of the protocols advocate compatibility. In this article, we argue that both parties often misinterpret the moral implications of the dead donor rule. The rule as such does not require an assessment of a donor’s vital status, we contend, but rather an assessment (...)
    Download  
     
    Export citation  
     
    Bookmark   24 citations  
  • (1 other version)The Dead Donor Rule and Means-End Reasoning - A Reply to Gardiner and Sparrow.Stephen Napier - 2012 - Cambridge Quarterly of Healthcare Ethics 21 (1):134-140.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Doing harm: living organ donors, clinical research and The Tenth Man.C. Elliott - 1995 - Journal of Medical Ethics 21 (2):91-96.
    This paper examines the ethical difficulties of organ donation from living donors and the problem of causing harm to patients or research subjects at their request. Graham Greene explored morally similar questions in his novella, The Tenth Man.
    Download  
     
    Export citation  
     
    Bookmark   18 citations  
  • (1 other version)The Dead Donor Rule and Means-End Reasoning.Robert Sparrow - 2012 - Cambridge Quarterly of Healthcare Ethics 21 (1):141-146.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Challenging research on human subjects: justice and uncompensated harms.Stephen Napier - 2013 - Theoretical Medicine and Bioethics 34 (1):29-51.
    Ethical challenges to certain aspects of research on human subjects are not uncommon; examples include challenges to first-in-human trials (Chapman in J Clin Res Bioethics 2(4):1–8, 2011), certain placebo controlled trials (Anderson in J Med Philos 31:65–81, 2006; Anderson and Kimmelman in Kennedy Inst Ethics J 20(1):75–98, 2010) and “sham” surgery (Macklin in N Engl J Med 341:992–996, 1999). To date, however, there are few challenges to research when the subjects are competent and the research is more than minimal risk (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • (1 other version)The Dead Donor Rule and Means-End Reasoning.Stephen Napier - 2012 - Cambridge Quarterly of Healthcare Ethics 21 (1):134-140.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • The Ethics of Dignity.John Laird - 1940 - Philosophy 15 (58):131 - 146.
    In the pages that are to follow I shall try to discuss the validity and the sufficiency of a celebrated moral principle of Kant's “So act as to treat humanity, whether in thine own person or in that of any other, always as an end, never merely as a means.” In doing so, I shall say quite a lot about Kant, because his statement of the principle has had great influence, because he gave his genius to its elaboration, because he (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • (1 other version)The Dead Donor Rule and Means-End Reasoning - A Reply to Napier.Robert Sparrow - 2012 - Cambridge Quarterly of Healthcare Ethics 21 (1):141-146.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • (1 other version)Medical experimentation, informed consent and using people.de An Cocking & Ju Stin Oakley - 1994 - Bioethics 8 (4):293-311.
    ABSTRACT In this paper we argue that the standard focus on problems of informed consent in debates about the ethics of human experimentation is inadequate because it fails to capture a more fundamental way in which such experiments may be wrong. Taking clinical trials as our case in point, we suggest that it is the moral offence of using people as mere means which better characterizes what is wrong with violations of personal autonomy in certain kinds of clinical trials. This (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations